| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Bright Now! Dental is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Irvine, CA. To find more information about Bright Now! Dental, please visit www.brightnow.com
e+CancerCare is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Insightra Medical is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Myelin Health is a network of companies linked by their experience and capabilities in the healthcare space. For payer and provider organizations, we create connections that make the most powerful messages mean even more. Myelin Health operates a strong and collaborative system of communication experts with capabilities in creative digital and traditional solutions, strategy and branding concepts, integrated marketing and advertising content, research, data and analytics, mobile engagement, design and more.